|
|
Informa Life Sciences
|
|
| Oncology & CNS Clinical Trials Summit |
|
|
|
|
|
|
| |
|
 |
|
|
|
|
| |
Wed 23 Apr 2008
- Thu 24 Apr 2008
Crowne Plaza London City, London, United Kingdom
|
|
|
|
2 FULL DAYS | CHOICE OF 2 STREAMS
ONCOLOGY | CNS
This brand new event has been carefully designed to give you all the fundamental tools to optimise your clinical trials. From preclinical development through to Phase III, there are unique challenges… and innovative solutions!
You will hear speakers from leading pharmaceutical firms, who are ready to help you to ensure that your non-inferiority trials are time and money well spent, and to use the forthcoming Paediatric Investigation Plan to your advantage.
We have gathered industry experts to impart their knowledge to you. In the current climate, every day saved in drug development can be worth millions. Learn to get the most out of your efforts and speed along your trials by optimising your patient recruitment, using intelligent project management, and utilising adaptive trial designs. If you work in oncology, hear the latest techniques in epigenetic and multiple receptor targeting. Those in neurology will discover the advantages of novel cognitive assessment methods, and how to adapt trials for disease modifying agents.
Take advantage of this unique summit to network with your peers working in another therapeutic area, and maybe some of their tips will refresh your own clinical trial work.
|
|
|
Who Will Attend?
- Heads of oncology
- Heads of CNS
- Clinical study managers
- Project managers
- Head of clinical services
- Business managers
- Directors of therapeutic research
- Chief medical officers
- Oncology group leaders
- CNS group leaders
- Biostatisticians
- Heads of drug discovery
|
Key Presentations
12.20 Day 1 - 23 April 2008:
Practical strategies for accelerating patient recruitment
- How to get the study started quickly
- How to alienate the clinician
- How to enthuse the study nurse
- How to win support from a clinical research network
- How to avoid the pitfalls for a pharma-driven trial
- How to enlist support from patients
Elaine Rankin, Professor of Cancer Medicine, University of Dundee, UK
13.30 Day 2 - 24 April 2008:
What are the roles of biomarkers in new drug development?
- Understanding the definition of biomarkers
- The discovery and validation of biomarkers
- Fit-for-purpose evaluation and validation
- Critical issues in the use of biomarkers
- The relevance of biomarkers in strategic decision making
Stephano Persiani, Director, Department of Drug Metabolism, Rottapharm Spa, Italy
|
|
|
|
|
|
|
|
|